Application no. and date | 05023971.4 (espacenet) (Federated) (European Patent Register), 20020129 | Patent/reg. no. and date | DK/EP 1621198, 20070523 | Publication date | 20060201 | Priority no. and date | US 770210, 20010129 | EP pub. no. and date |
EP 1621198 20060201 | Effective date | | Applicant/owner | OTSUKA PHARMACEUTICAL CO., LTD., 9, Kandatsukasa-cho 2-chome
Chiyoda-ku Tokyo 101-8535, JP | Applicant ref. no. | p200501302DK00E | Inventor | TOTTORI, Katsura, 15-1, Kamirokujo, Kamiitacho
Itano-gun, Tokushima 771-1345, JP, UWAHODO, Yasufumi, 70-8, Aza Miyanomae, Oujincho Furukawa
Tokushima-shi, Tokushima 771-1151, JP, JORDAN, Shaun, 3641 Byron Place, Urbana, Frederick
Maryland, MD 21704, US, KIKUCHI, Tetsuro, 157-13, Kawauchicho Komatsunishi
Tokushima-shi, Tokushima 771-0104, JP, Hirose, Tsuyoshi, 8-9-502.Sako Ichibancho
Tokushima-shi, Tokushima 770-0021, JP | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/496 (2006.01) , A61K 45/06 (2006.01) , A61P 25/18 (2006.01) , A61P 25/28 (2006.01) | Title | Substituerede carbostyrilderivater som 5-HT1A-receptorsubtype-agonister | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | Ophævet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|